Kane Biotech Inc. (CVE:KNE – Get Free Report) shares shot up 8% during mid-day trading on Monday . The stock traded as high as C$0.15 and last traded at C$0.14. 31,500 shares were traded during mid-day trading, a decline of 65% from the average session volume of 89,338 shares. The stock had previously closed at C$0.13.
Kane Biotech Price Performance
The company has a 50 day moving average of C$0.11 and a 200-day moving average of C$0.08. The firm has a market capitalization of C$18.46 million, a P/E ratio of -4.67 and a beta of 0.56. The company has a current ratio of 0.37, a quick ratio of 0.39 and a debt-to-equity ratio of 1,164.24.
Kane Biotech (CVE:KNE – Get Free Report) last released its quarterly earnings results on Tuesday, March 26th. The company reported C($0.01) earnings per share (EPS) for the quarter. The company had revenue of C$0.04 million during the quarter.
Kane Biotech Company Profile
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; and animal and human wound care solutions under the DispersinB name.
Featured Articles
- Five stocks we like better than Kane Biotech
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Silicon Motion Proves That AI in Motion Stays in Motion
- What is a Dividend King?
- Undervalued UnitedHealth Group Won’t Be For Long
- Election Stocks: How Elections Affect the Stock Market
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
